Table 1. Brief overview of breast cancer cell line-derived xenograft (CDX), patient-derived xenograft (PDX) and syngeneic mouse models.
Implantation site | Mice strain | Cell line | Subtype | ER | PR | HER2 | References | ||
---|---|---|---|---|---|---|---|---|---|
CDX model | subcutaneous CDX | Subcutaneous | BALB/c, Nude | MDA-MB-231 | Basal | − | − | − | [18] |
MDA-MB-435 | Basal | − | − | − | [54] | ||||
BT-474 | Luminal B | + | + | + | [55] | ||||
Orthotopic CDX | Mammary fat pad | NOD/SCID | MDA-MB-231 | Basal | − | − | − | [22] | |
MDA-MB-435 | Basal | − | − | [23] | |||||
SUM1315 | Basal | − | − | [24] | |||||
MCF7 | Luminal A | + | + | [25] | |||||
T47D | Luminal A | + | + | [26] | |||||
Metastatic CDX | Tail vein | NOD/SCID | MDA-MB-231 | Basal | − | − | − | [56] | |
SUM149 | Basal | − | − | [57] | |||||
PDX model | Subcutaneous | BALB/c, Nude | [58] | ||||||
Mammary fat pad | NOD/SCID | [59] | |||||||
Mammary fat pad | NSG | [60] | |||||||
Humanized Mammary fat pad | NOD/SCID | [61] | |||||||
Syngeneic model | Mammary fat pad | BALB/c | 4T1 | - | - | - | [38] |